Bruker Expects Close to $70M in Q1 Revenues | GenomeWeb

NEW YORK, April 21 (GenomeWeb News) - Bruker BioSciences expects between $68 million and $69 million in revenues and $.01 in earnings per share for the first quarter, the company said today.

 

Bruker plans to announce its full financial results for the first quarter on May 4.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.